Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3062|17|5|695-701

ISSN： 1398-2273

Source： TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol.17, Iss.5, 2015-10, pp. : 695-701

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 1398-2273, Iss. 5, 2015-10 ,pp. : 695-701

John Wiley & Sons Inc

Access to resources Recommend Favorite

Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen–positive liver transplant recipients after longterm minimal immunosuppression

By  

LIVER TRANSPLANTATION, Vol. 22, Iss. 9, 2016-09 ,pp. : 1205-1213

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevention of Hepatitis B Virus Reinfection in Liver Transplant Recipients

By  

Intervirology, Vol. 57, Iss. 3-4, 2014-07 ,pp. : 196-201

Karger

Access to resources Recommend Favorite

Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 18, Iss. 5, 2016-10 ,pp. : 667-673

John Wiley & Sons Inc

Access to resources Recommend Favorite

High Prevalence of Hepatitis B Nonimmunity in Vaccinated Pediatric Liver Transplant Recipients

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 2, 2015-02 ,pp. : 535-540

John Wiley & Sons Inc

Access to resources Recommend Favorite